Essilorluxottica (EL)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
€247.70
Buy
€250.70
€6.80 (+2.81%)
Prices updated at 12 May 2025, 16:35 CEST
| Prices minimum 15 mins delay
Prices in EUR
Essilor International SA designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures purchases and sales frames, sunglasses and other protective equipment, lenses and contact lenses.
1.29%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Francesco Milleri
CEO
Mr. Francesco Milleri
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
200,000
Head office
147, Rue de Paris
Paris
France
94220
Key personnel
Owner name | Salary |
---|---|
Mr. Paul du Saillant Deputy Chief Executive Officer and Director | - |
Ms. Marie-Christine Coisne-Roquette Independent Director | - |
Dr. Swati A. Piramal Independent Director | - |
Mr. Mario Notari Director | - |
Mr. Francesco Milleri Chief Executive Officer and Chairman of the Board | - |
Ms. Cristina Scocchia Independent Director | - |
Mr. Andrea Zappia Independent Director | - |
Mr. Romolo Bardin Director | - |
Mr. Jean-Luc Biamonti Independent Director | - |
Dr. Nathalie von Siemens Independent Director | - |
Ms. Virginie Mercier Pitre Director | - |
Ms. Margot Bard Director | - |
Mr. Sebastien Brown Director | - |
Mr. Jose Gonzalo Independent Director | - |
Top 5 shareholders
Owner name | No. of shares |
---|---|
Capital Research and Management Company | 20,252,458 |
Capital Group | 18,783,258 |
Vanguard Group Inc | 8,884,847 |
American Funds New Perspective Fund | 7,446,311 |
Capital Group New Perspective Comp | 7,446,311 |
Director dealings
Date | Action |
---|---|
No data |
Please note that past performance is not a reliable indicator of future returns.